Skip to content

13F-HR filed by MPM BIOIMPACT LLC

MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 33 holding rows worth $644,675,000.

Accession
0000950123-21-015022
Filed
2021-11-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2021

A holdings report, 33 entries on the cover page, a total value of $644,675,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $644,676,000 with VALUE read as thousands by filing date, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CULLINAN THERAPEUTICS INC230031106COM7,648,268$172,621,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM2,107,092$56,891,000thousands by filing date
REPARE THERAPEUTICS INC760273102COM1,639,849$43,030,000thousands by filing date
WEREWOLF THERAPEUTICS INC95075A107CMN2,388,011$40,978,000thousands by filing date
MEI Pharma, Inc.552798202Common12,494,118$34,484,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM3,370,982$28,687,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM3,196,707$25,254,000thousands by filing date
ONCORUS INC68236R103COM2,377,031$22,201,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM162,620$21,815,000thousands by filing date
MERUS N VN5749R100COM941,948$20,723,000thousands by filing date
EPIZYME INC29428V104COM3,972,830$20,341,000thousands by filing date
TURNING PT THERAPEUTICS90041T108COM271,350$18,026,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock452,970$12,928,000thousands by filing date
G1 THERAPEUTICS INC3621LQ109COM860,502$11,548,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock704,767$10,128,000thousands by filing date
ADC THERAPEUTICS SAH0036K147COMMON STOCK344,519$9,357,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW247,291$8,838,000thousands by filing date
VERASTEM INC92337C104COM2,824,857$8,701,000thousands by filing date
GERON CORP374163103COM5,732,770$7,854,000thousands by filing date
TRAVERE THERAPEUTICS INC89422G107COM306,515$7,433,000thousands by filing date
NEOGENOMICS INC64049M209COM NEW149,504$7,212,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock298,392$6,281,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM308,532$6,146,000thousands by filing date
HARMONY BIOSCIENCES HLDGS IN413197104COM151,650$5,813,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW683,287$5,466,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM546,558$5,220,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock861,858$4,809,000thousands by filing date
LUCIRA HEALTH INC54948U105COM578,114$4,394,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock150,000$4,127,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO400,000$3,920,000thousands by filing date
INOZYME PHARMA INC45790W108COM320,724$3,717,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock110,155$3,631,000thousands by filing date
BLACK DIAMOND THERAPEUTICS I09203E105COM248,506$2,102,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-21-015022this filing2021-11-15acceptance time not in the bulk data set